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wileyonlinelibrary.comrther endeavors to combat antibiotic1. Introduction
‘‘No action today, no cure tomorrow’’ The World Health
Organization (WHO) recently published its global strategyto stimulate fu
resistant bacteria.[1,2] The WHO advocates that anti-
microbial resistance is not a new problem but one that
is becoming more dangerous.[3] A high percentage of
healthcare-associated or hospital-acquired infections
are caused by antibiotic-resistant bacteria including
methicillin-resistant Staphylococcus aureus (MRSA) and
vancomycin-resistant Enterococcus (VRE). Most recently,
the emergence of ‘‘totally drug resistant’’ M. tuberculosis
was described from clinical isolates in South Africa.[4]
These resistant bacteria cause adverse infections, result-
ing in prolonged illness, complications to existing
conditions, and can often result in mortality. The
prevalence of drug resistance also rapidly diminishes
the available treatment options, adding tremendous costs
and burdens to the health care system worldwide.[5–10]
However, the number of new antibiotics, not just new
formulations of existing ones, has fallen steadily in
the past few decades.[11] This is because it is a scientific
challenge to develop new classes of antimicrobialDOI: 10.1002/mabi.201300126 1285
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1286materials withmolecular mechanisms that can overcome
acquired resistance and do not contribute to resistance
development. Effective approaches for newer and
stronger antibiotics are in urgent need to ensure the
future treatment options for drug resistant infections as
well as prevention of new resistance development.
Many of the clinically prevalent antibiotics are
enzyme inhibitors and DNA replication inhibitors, which
disrupt the essential bacterial cellular biosynthesis of
nucleic acids, proteins, or cell wall components.[12] Because
antibiotics target specific components in biosynthetic
pathways which do not exist in humans, the antimicrobial
development has been directed to identification and
characterization of such molecules with high affinity for
the bacterial target. However, bacteria can rapidly acquire
resistance against these antibiotic drugs by numerous
mechanisms including enzymes which destroy antibiotic
agents, efflux pumps which excrete antibiotics from cells,
or mutations which alter antibiotic target sites.[13,14] In
addition, resistance to one drug often triggers multi-drug
resistance.[5,9] The hurdle of rapid resistance development
in bacteria is compounded by man-made hurdles as
the number of new antibiotics in the development
pipeline has declined: simply put, the conventional drug
discovery approach cannot keep up with the pace of
resistance development in bacteria. This is because it has
been difficult to find new antimicrobial mechanisms of
action which are intrinsically insensitive to the emergent
and/or existing resistance mechanisms in bacteria.[8]
Therefore, it is critical to use creative scientific solutions
for a new era of antimicrobial development to fight
against resistance in bacteria.
To that end, host-defense antimicrobial peptides and
their synthetic mimics have emerged as candidates
for new antibiotics.[15–18] Antimicrobial peptides have
been identified and isolated from many organisms
including plants, insects, and animals. Theses peptides
are featured by cationic, amphiphilic nature accompanied
with secondary structures including a-helix, b-sheet,
loop, and extended structure.[19] The proposedmechanism
of action for the majority of these antimicrobial peptides
is by acting on bacterial cell membranes. The peptides
bind to the bacterial cell surface by electrostatic inter-
actions between cationic side chains of the peptide
and negatively charged components of the bacterial cell
wall and membrane(s). The accumulation of peptides on
the cell surface leads to membrane disruption, resulting
in a breakdown of the membrane potential, leakage of
cellular components, and bacterial cell death. Since all
bacteria require an in-tact cytoplasmic membrane, the
mode of action of antimicrobial peptides targeting cell
membranes is effective against drug-resistant bacteria
and less susceptible to the resistance mechanisms in
bacteria. However, the implementation of peptides asMacromol. Biosci. 201
 2013 WILEY-VCH Verlag GmbHnewantibiotics have significant obstacles associatedwith
bioavailability, high manufacturing cost, and unknown
systemic toxicity.[20]
To create new antimicrobial materials effective to drug
resistant bacteria, our laboratories have extended the
molecular mimicry of antimicrobial peptides to create
antimicrobial materials based on conventional synthetic
polymers such as methacrylate (Figure 1).[18,21–31] These
polymers are designed to mimic the cationic functionality
and amphiphilic nature of antimicrobial peptides,
designed to act as membrane-active antimicrobial agents.
The synthetic polymers such as methacrylate have
been used as a molecular platform, and cationic and
hydrophobic groups are randomly distributed along
the polymer chains. These random copolymers do not
have intrinsically programmed secondary structures such3, 13, 1285–1299
& Co. KGaA, Weinheim www.MaterialsViews.com
Figure 1. Antimicrobial synthetic copolymers mimicking antimicrobial peptides.
Antimicrobial copolymers are synthetic methacrylate random copolymers bearing
cationic primary ammonium groups (red) and hydrophobic ethyl groups (blue) in the
side chains. The methacrylate backbone was colored green. Antimicrobial peptides are
a-helical cationic antimicrobial peptide magainin. Cationic residues (blue) and
hydrophobic residues (green) are segregated into the opposite sides of helix. The
backbone structure was colored gray. Reprinted with permission[18,49] Copyright 2012
American Chemical Society and Copyright 2012 Wiley Periodicals, Inc.
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www.mbs-journal.deas a-helix and b-sheet and have random sequence of
cationic and hydrophobic groups, which contrast the
homogeneous structures of peptides. Therefore, it has
been a scientific challenge for our and other laboratories
in this field to provide the basis that these synthetic
polymers are capable of exerting antimicrobial peptide-
like activity. However, a number of studies on anti-
microbial polymers with good efficacy have been docu-
mented recently,[17,32–38] and the number of reports is
increasing, supporting this new design concept of
antimicrobial polymers. The availability of chemical and
structural diversity of synthetic polymers has further
extended this research field to include new scientific
investigation of polymer architectures for use as anti-
microbial macromolecules.[32,39]
In this feature article,wediscuss our approach todevelop
cationic amphiphilic polymers as antimicrobial agents and
modulate their antimicrobial activity bymolecular design,
which has been inspired by natural antimicrobial peptides.Figure 2. Synthesis of methacrylate random copolymers with cationic amphiphilic structu
hexyl, and benzyl groups). The polymers were prepared from boc-protected amine monom
The polymerization was performed using azobisisobutylonitrile (AIBN) as a radical initiat
transfer agent in acetonitrile. The treatment of boc-protected polymers by trifluoroa
copolymers with cationic ammonium groups in the side chains.
Macromol. Biosci. 2013, 13, 1285–1299
 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinwww.MaterialsViews.comWe also discuss the structural determi-
nants to control their antimicrobial
activity and toxicity to human cells. To
support these discussions, the results
from biophysical experiments are de-
scribed,whichquantified themembrane-
binding of polymers and examined the
role of ammonium groups in the inter-
actions of polymers with membranes. In
addition, our recent report on the antimi-
crobial activity of conventional poly
(ethylene imine)s (PEIs), widely used as
a gene carrier in drug delivery system,
is discussed as new model polymers to
investigate the mode of antimicrobial
action of cationic polymers.[40] The focus
of this paper is our approach with the
peptide-mimetic design of antimicrobial
polymers rather than an overview of
reported literature on other materials.
For more detailed and comprehensivediscussions on preparation and efficacies of specific
antimicrobial polymers, we encourage the readers to
examine a number of excellent review articles referenced
here.[17,33,34,37,41,42]2. Design and Activity of Cationic
Amphiphilic Antimicrobial Polymers
2.1. Design and Synthesis of Antimicrobial
Methacrylate Copolymers
Based on the peptide-mimetic design, we have been
interested in developing antimicrobial polymers using
conventional polymer platform of methacrylate, which
have no intrinsic secondary structures like peptides. We
synthesized poly(methacrylate)s bearing cationic and
hydrophobic groups in the side chains,which are randomly
distributed in a polymer chain (Figure 2).[21] These
methacrylate random copolymers have primaryres. R: hydrophobic groups (methyl, ethyl, butyl,
er and alkyl or benzyl methacrylate monomers.
or and methyl 3-mercaptopropionate as a chain
cetic acid (TFA) gave the amphiphilic random
heim 1287
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1288ammonium groups as cationic sources, mimicking the
cationic functionality of lysine residues which are abun-
dant in naturally occurring and designed antimicrobial
peptide sequences although quaternary ammonium
groups have been traditionally used for antimicrobial
polymers.[17,37,41] The cationic functionality of copolymers
was expected to provide enhanced binding to bacterial
surfaces by electrostatic attraction as in the antimicrobial
peptide design template.We synthesized the copolymers in
the presence of a chain transfer agent methyl 3-mercapto-
propionate to prepare low molecular weight (MW) poly-
mers (MW¼ 1 000–10000 g mol1) to match with the
relatively low MWs of antimicrobial peptides (a few kDa).
To control the balance between net cationic charge and
hydrophobicity, the mole percentages of hydrophobic
groups (MPHB)were varied from0 (cationic homopolymers)
to 60 mol-%. In general, the copolymers with higher MPHB
of hydrophobic groups are not soluble in water which
inherently limits the functionality of these compounds.2.2. Antimicrobial and Hemolytic Activities of
Methacrylate Copolymers
We first examined the antimicrobial activity of cationic
copolymers with butyl methacrylate as the hydrophobic
moiety (Figure 3A).[21] We synthesized a series of randomFigure 3. Antimicrobial and hemolytic activities of cationic amphip
Molecular weight dependence. Each series of polymers have averag
dependence. Low MW polymers with different hydrophobic groups
activity against human RBCs. The data are adapted with permission[2
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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 2013 WILEY-VCH Verlag GmbHcopolymers with three different MW ranges (average
MW¼ 1 600, 5 000, and 8 700 g mol1). We determined
the minimum inhibitory concentration (MIC), which is
the lowest polymer concentration to completely inhibit
bacterial growth in solution, as a measure of antimicrobial
activity. As a reference, a lower MIC value indicates a
higher efficacy of antimicrobial activity (i.e., less of the
antimicrobial material is required to inhibit bacterial
growth). For all the polymer series, the MIC values against
Escherichia coli decreased as the MPHB of butyl groups
increased and leveled off above 30 mol-%. This indicates
that the hydrophobicity of polymers is one of the driving
forces for the antimicrobial activity, but any further
increase in hydrophobicity does not contribute to the
further increases in activity (Figure 3B). Comparing the
MICs of these polymers, the polymers with lowest MWs
(MW¼ 1 300–1 900 g mol1) showed lowest MIC values
(MIC¼ 16mg mL1) above the MPHB> 30 mol-%. We
speculate that low MW polymer chains may be able to
penetrate the cell wall structure of E. coli more effectively
than high MW counterparts. We also consider that low
MW of polymers yields a greater number of moles of
polymer chains in a given unit of weight-based concentra-
tion compared to the high MW polymers.
Considering use of these copolymers as antimicrobial
materials, it is important to evaluate their toxicity tohilic methacrylate random copolymers. (A) Polymer structures. (B)
e MW of 1 600, 5 000, and 8 700 g mol1. (C) Hydrophobic group
were tested for antimicrobial activity against E. coli and hemolytic
1,23] Copyright 2005 American Chemical Society and Copyright 2009
3, 13, 1285–1299
& Co. KGaA, Weinheim www.MaterialsViews.com
Molecular Design, Structures, and Activity . . .
www.mbs-journal.dehuman cells. We measured hemolytic activity against
human red blood cells (RBCs) as an initial assessment of
toxic effect of copolymers to human cells. We determined
HC50, which is a polymer concentration for 50% hemolysis.
The HC50 values decreased as the MPHB of butyl groups
increased, indicating hemolytic activity of polymers is also
enhanced by hydrophobicity of polymers. Similar to the
MICs, the HC50 values also level off at high MPHB of butyl
groups. Interestingly, the HC50 values of the polymer series
with lowest MWs (MW¼ 1300–1 900 g mol1) were
magnitudes higher than those of high MW counterparts.
This result indicates that the hemolytic activity of these
copolymers can be reduced by designing low MWs of
copolymers, which mimic the molecular size of natural
antimicrobial peptides.
The previous results suggested that polymers with
small molecular sizes (low MWs) would be a good
platform to prepare non-toxic antimicrobial polymers.[21]
The results also indicated that the hydrophobicity of
polymers enhances their antimicrobial activity, but the
excess hydrophobicity renders the polymers toxic. There-
fore, it is necessary to hit the right balance between
hydrophobicity and cationic functionality to maximize
the antimicrobial activity and minimize the hemolytic
activity. To that end, we further examined the effect of
side chain hydrophobicity on the antimicrobial and
hemolytic activities of these copolymers (Figure 3C).[23]
We synthesized low MW (1 600–2 000 g mol1) cationic
methacrylate copolymers with different hydrophobic
groups including methyl, ethyl, butyl, hexyl, and benzyl
groups. The MIC values for E. coli decreased as the MPHB
of hydrophobic groups increased and leveled off in high
MPHB regions. The lowest MIC at high MPHB is almost the
same value (16mg mL1) for all copolymers tested. The
MPHB at the transition from high to lowMIC values shifted
to smaller MPHB as the alkyl chain length decreased. This
result supports the notion that hydrophobicity of polymers
enhances the antimicrobial activity against E. coli.
Next, the effect of hydrophobic groups on the hemolytic
activity of copolymers was assessed by HC50 values. The
HC50 values decreased as MPHB increased, and the curves
were shifted to smaller MPHB as the alkyl chain length
decreased (Figure 3B,C). For the copolymerswith short alkyl
chains (methyl and ethyl groups), the HC50 values are
higher thanMIC values at the sameMPHB, indicating these
copolymer series are selective to bacteria over human cells.
However, the copolymers with longer alkyl chains showed
lower HC50 values, resulting in no selectivity to bacteria
over human cells. This is likely because the short alkyls
provide small increments in the net hydrophobicity of
copolymers, allowing fine-tuning of amphiphilic balance
for high antimicrobial activity (lowMIC) of copolymers and
low hemolytic activity (high HC50). These results suggest
that the antimicrobial and hemolytic activities of polymersMacromol. Biosci. 20
 2013 WILEY-VCH Verlag Gmwww.MaterialsViews.comcan be controlled by careful tuning of polymer structures
for optimal amphiphilic balance and molecular size. The
peptide-mimetic approachhas also beenundertakenby the
research groups, specifically investigating the structure–
antimicrobial activity relationship using a variety of
alternative polymer platforms including, for example,
polynorbornene,[35] nylon,[38,43] poly(phenyleneethynyl-
ene)s,[44] polymethacrylamide.[25] These studies also
reached the same conclusion that the cationic amphiphilic
balance is the key determinant for the selective activity of
polymers against bacteria over human cells. This indicates
that the underlying design principle seems to be applicable
formany synthetic polymer structures. In addition to these
random copolymers, the effect of spatial separation of
cationic groups and hydrophobic groups has been previ-
ously investigated using pyridinium–methacrylate co-
polymer.[45] A series of polymers have cationic pyridines
modified with hydrophobic tails on the ‘‘same center’’,
which are non-hemolytic antimicrobial materials. On the
other hand, polymers with separation of the cationic
and hydrophobic tails in the different side chains onto
‘‘different centers’’ are antimicrobial, but also hemolytic.
We have also demonstrated the segregated amphiphilic
structures significantly affect their biological activities.
Amphiphilic vinyl ether block copolymers with separated
cationic and hydrophobic block segments showed low
hemolytic activity whereas random copolymer counter-
parts showed high hemolytic activity.[46] Recently, Song
et al. also investigated the effect of the exact distance of
ammonium groups along the backbone using alternating,
random, and uniform structures on antimicrobial activi-
ty.[47] The results indicated that the hydrophobic spacer
distance along thepolymerbackbonebetweenneighboring





. These reported studies indicate that the synthetic
polymer platforms are able to provide a diversity of
amphiphilic structures, sequences, and spatial arrange-
ments to explore structural parameters to mimic the
function and structural features of antimicrobial peptides.2.3. Bactericidal Kinetics and Susceptibility to
Resistance
Using representative copolymers PM63 and PB27, which are
methacrylate copolymers with 63 mol-% methyl group
and 27 mol-% butyl groups, respectively, we assessed
the potential of these copolymers as antimicrobial agents.
We first determined how quickly these polymers can
reduce the number of viable E. coli cells in a solution growth
phase (bactericidal kinetics) (Figure 4A).[30] At a concentra-
tion of twice the MIC, the PM63 and PB27 killed 99.99%
of bacteria within 60min for E. coli. For comparison,
pexiganan, synthetic derivative of magainin was reported
99.9% killing of E. coliwithin one hour at the concentration13, 13, 1285–1299
bH & Co. KGaA, Weinheim 1289
Figure 4. Bactericidal kinetics and susceptibility to resistance in bacteria. (A)
Bactericidal kinetics of methacrylate copolymers against E. coli. The polymers are
methacrylate copolymers with methyl group (PM63, MPHB¼63 mol-%, DP ¼ 17) and
butyl groups (PB27, MPHB¼ 27 mol-%, DP ¼ 16) as hydrophobic side chains. The viable
account below 100 CFU mL1 was not determined due to the detection limit of this
assay condition. (B) Susceptibility to resistance in E. coli. E. coli was cultured in the
presence of polymers at the half of MIC, and 21 passages did not result in resistance
development while conventional antibiotics showed up to 512-fold (norfloxacin) or 256-
fold (ciprofloxacin) increase in their MICs. See ref.[30] for experimental details. The data
are adapted from our previous report.[30]
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1290of twice theMIC.[48] These results indicate that the activity
of these copolymersare comparable to thatof antimicrobial
peptides.
Additionally, we also determined the susceptibility of
the PM63 andPB27 copolymers to development of resistance
in E. coli.[30] E. coli was sub-cultured in liquid media
containing sub-inhibitory concentrations (one-half MIC)
of each polymer, and the MIC of these copolymers was
determined after each passage. The E. coliwas sub-cultured
again at the half of theMIC determined after each passage,
and this procedure was repeated for up to 21 passages
(Figure 4B). The MIC values of PM63 and PB27 against the
cultured E. coli after each passage were constant within a
single twofold dilution through all 21 passages. In contrast,
the MIC values of norfloxacin and ciprofloxacin (FDA
approved drugs that act as DNA synthesis inhibitors)
increased, and finally reached 512- or 256-fold MIC after
21 passages, respectively. This result indicates that
these copolymers are not susceptible to the resistance
mechanisms inE. coliunder theseconditions. Inaddition, the
E. coli resistant to norfloxacin and ciprofloxacin remain
susceptible to the PM63 and PB27 copolymers with the same
MIC values as the original antibiotic susceptible strain.
Similarly, the E. coli culture passaged with the copolymers
maintains susceptibility to the norfloxacin and ciprofloxa-
cin. These results indicate that the copolymers do not
contributetothedevelopmentofcross-resistanceinbacteria.
It should be noted that the acquired resistance in bacteria
to these antibiotics was persistent after 15 antibiotic-free
passages, indicating that the antibiotic resistance was not
simply physiological adaption in bacteria.Macromol. Biosci. 2013, 13, 1285–1299
 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinhei3. Modulating Antimicrobial
Activity by Peptide-inspired
Design
We have been interested in controlling
the antimicrobial activity of synthetic
copolymers by designing their molecular
structures. As described above, our mo-
lecular design of antimicrobial copoly-
mers is based on the mimicry of natural
antimicrobial peptides. We further ex-
tended our peptide-mimetic approach to
utilize the ‘‘snorkeling’’ effect well char-
acterized in peptides to control the
interaction of polymer chains with cell
membranes.[49] The snorkeling model
is one in which peptides have long
spacer arms in the cationic residues
(lysine and arginine), which can reach
to the lipid–water interface, allowing the
hydrophobic peptide helices to localize
in the hydrophobic domains of lipid
bilayers.[50–54] The snorkeling effect hasbeen utilized for stabilizing hydrophobic transmembrane
peptides in model and cell membranes. Inspired by this
peptide design, we hypothesized that the snorkeling
effect will facilitate polymer insertion to cell membranes
for potent antimicrobial activity. Accordingly, we synthe-
sized cationic amphiphilic copolymers with elongated
cationic spacer arms of ethylene (E2), butylene (E4), and
hexane (E6) (Figure 5A).[49] We chose ethyl methacrylate
as a hydrophobic co-monomer because, as mentioned
above, the short alkyl side chains can provide a means of
fine-tuning overall hydrophobicity of the polymers for
optimizing selective activity against bacteria over human
cells. In the polymerization, the boc-protected amine
monomers and ethyl methacrylate were consumed at
nearly identical rates, indicating the random incorporation
of these monomers into the polymer chains.[49] The
representative copolymers displayed antimicrobial activi-
ty against a broad spectrum of bacteria including
community-associated MRSA.[49] The MIC values de-
creased as the length of spacer arms increased, indicating
that the antimicrobial activity is enhanced by the
elongation of spacer arms. The HC50 values of copolymers
also decreased with elongation of spacer arms, indicating
the hemolytic activity increased. From these results,
the copolymer E428 (MPHB¼ 28%, DP ¼ 12.5) showed a
good balance between low MIC and high HC50 values,
indicating potent activity, but low hemolytic activity.
These results indicate that the copolymers can be
controlled by fine-tuning of the spacer arm length to
give selective activity to bacteria over human cells. To
investigate the snorkeling effect on the interactions ofm www.MaterialsViews.com
Figure 5. Antimicrobial polymers based on snorkeling design. (A) Polymer structures
with elongated cationic spacer arms. (B) Characteristics and properties of methacrylate
copolymers with elongated cationic spacer arms. a)Mole percentage of ethyl group
(MPethyl) and the degree of polymerization (DP) were determined by 1H NMR analysis.
The number-average molecular weight (Mn) was calculated based on the MPethyl and
DP . (C) Snapshot of polymer chains in lipid bilayers. (D) Polymer conformations in the
XZ-plain of lipid bilayers. Reprinted with permission[49] Copyright 2012 American
Chemical Society.
Molecular Design, Structures, and Activity . . .
www.mbs-journal.depolymers with lipid membranes, we examined the
conformation of polymer chains in bacterial cell mem-
branes by molecular dynamics simulations (Figure 5C,D).
The result showed that the E2 model polymer is localized
on the bilayer surface, and the polymer chain folds
into a compact conformation likely due to hydrophobic
collapse of polymer chains upon exposure to water. On
the other hand, the polymer chains of E4 and E6 are
inserted into the hydrophobic region of the bilayer, and
the polymer backbone is relatively stretched. In addition,
the cationic ammonium groups and ethyl side chains of
ethyl methacrylate are segregated to the opposite side
relative to the polymer backbone. The cationic groups
appear to be interacting with phosphate from the lipid
head groups, likely through an electrostatic interaction.
These results indicate that the polymers can develop
segregated amphiphilic structures upon binding to lipid
membranes. Ingeneral, cationic amphiphilic antimicrobial
peptides such as magainins and LL-37 adopt an a-helical
conformation upon binding to cell membranes, in which
cationic and hydrophobic residues are segregatedMacromol. Biosci. 2013, 13, 1285–1299
 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinwww.MaterialsViews.comto opposite side of the a-helix.[15,16,55]
Although the copolymers are not likely
to have anydefined secondary structures
such as an a-helix, the polymer chains
can adopt their conformation to form
similarly segregated cationic amphi-
philic structures in cell membranes as
peptides do. These results may indicate
that such cationic amphiphilic structure
is a key determinant for antimicrobial
activity of peptides and polymers rather
than the sequence and secondary con-
formation of polymers. Gellman and
coworkers previously demonstrated that
random nylon copolymers with cationic
amphiphilic structures display high
antimicrobial potency and selective
activity against bacteria over human
cells, which is based on the hypothesis
that these copolymers are capable of
forming a segregated amphiphilic con-
formation upon binding to bacterial
cell membranes.[38,43] Yethiraj and co-
workers also previously reported that
random copolymer b-peptide models
also adopt the segregated amphiphilic
conformation in lipid membrane.[56]
These results support the design ap-
proach of antimicrobial polymers that
amphiphilic copolymers can exert an
antimicrobial effect by mimicking the
segregated amphiphilic structure of pep-
tides, but it does not necessarily requirethe clearly defined facially amphiphilic secondary struc-
tures like peptides.4. Mechanistic Studies by Biophysical
Methods
4.1. Polymer Binding to Lipid Membranes
We have been interested in quantifying interactions
between the amphiphilic copolymers and cell membranes,
which we hypothesize, determine the antimicrobial and
hemolytic activities of these copolymers. To that end, we
designed experiments to determine the binding properties
of the amphiphilic copolymers to model lipid membranes
using fluorescent dansyl-labeled polymers and large
unilamellar vesicles (LUVs) or giant unilamellar vesicles
(GUVs) (Figure 6).[23] The fluorescence properties of the
dansyl group are sensitive to polarity of surrounding
environment such that the emission spectrum of dansyl
group shifts to shorter wavelengths (blue-shift) and theheim 1291
Figure 6. Polymer-binding to lipid bilayers. (A) Polymer synthesis of dansyl-labeled
methacrylate copolymers. (B) Characteristics and of dansyl-labeled methacrylate
copolymers. a)Mole percentage of butyl group (MPbutyl) and the degree of
polymerization (DP), were determined by 1H NMR analysis. The number-average
molecular weight (Mn) was calculated based on the MPbutyl and DP . (C) Confocal
image of GUVs of POPC/POPG (1:1) incubated with dansyl-labeled methacrylate
copolymers (unpublished data). (D) Binding isotherms of dansyl-labeled methacrylate
copolymers to liposomes. The data are adapted with permission[23] Copyright 2009
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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1292emission intensity increaseswhen transferred froma polar
(aqueous) to a non-polar (hydrophobic) environment. We
expected that the emission from the dansyl groups
conjugated to the polymer chains would increase along
with blue shiftwhen the polymers are transferred from the
aqueous milieu to the hydrophobic environment of lipid
membranes.[57] Thus, we prepared methacrylate copoly-
mers modified with a dansyl group at the polymer end
(Figure 6A,B). Fluorescence microscopy of GUVs composed
of POPC/POPG (1:1mol:mol) was fluorescent after addition
of dansyl-labeledmethacrylate copolymers, supporting the
notion that the dansyl groups bind to the hydrophobic
domains of lipid membranes and yielding a signal for
polymer binding (Figure 6C). Likewise, the emission
intensity from the dansyl groups increased with titration
of liposomes, indicating that the dansyl groups inserted
into the lipid bilayer when the copolymers are bound to
liposomes. Accordingly, the binding isotherms of the
copolymers were obtained by monitoring the emission
intensity of dansyl-labeled copolymers upon titrationwith
LUVs (Figure 6D). We used liposomes consisting of POPC or
POPE/POPG (8:2) as a model bilayer composition to mimicMacromol. Biosci. 2013, 13, 1285–1299
 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheihuman RBC membranes or bacterial cell
membranes, respectively (Figure 6D). To
extend this avenue of study, we used
a series of dansyl-labeled copolymers
(D0, D27, and D49) with different compo-
sitions of butyl methacrylate (0, 27,
and 49 mol-%) to examine the effect of
hydrophobic contents on their mem-
brane binding behavior.
Using this approach, we were able
to determine the dissociation constant
(Kd) of each copolymer by curve fitting
analysis. In general, the dissociation
constant Kd values of copolymers de-
creased as theMPHB ofhydrophobic butyl
groups of copolymers increases for both
of neutral RBC-mimetic and the anionic
bacterial-mimetic membrane composi-
tions. This indicates the net hydropho-
bicity of the polymers enhances binding
to membrane regardless of anionic
charge carried on the lipid headgroup.
On the other hand, this series of meth-
acrylate copolymers (D0, D27, and D49)
showed lower Kd values for POPC lip-
osomes than those of POPE/POPG lip-
osomes, indicating that thesecopolymers
preferentially bind RBC-mimetic lipid
compositions over bacterial-mimetic
ones. This result reflects the relatively
high hemolytic activity of these copoly-
mers with butyl side chains againsthuman RBCs. It is interesting that the Kd values displayed
only maximum fourfold increase as the MPHB of butyl
groups increased from 0 to 49mol-%while the HC50 values
of corresponding polymers without dansyl groups de-
creased up to 100-fold. This result suggests that the activity
of polymers against cell membranes is determined by not
only binding, but also the subsequent mechanism of
membrane disruption or pore formation upon binding the
membrane. We have previously demonstrated that the
hemolysis induced by methacrylate copolymers is caused
by osmotic lysis due to the formation of nanosized pores in
the RBCmembranes.[29] Itwill benecessary to further study
the inter-relationship among polymer hydrophobicity,
hemolytic activity, and underlying mechanism of bilayer
disruption for the de novo polymer engineering principles
to design non-toxic antimicrobial polymers.4.2. Role of Amine Functionality in Antimicrobial
Mechanism
In our polymer design, primary ammoniumgroups serve as
the source of cationic charge. We initially selected thesem www.MaterialsViews.com
Molecular Design, Structures, and Activity . . .
www.mbs-journal.deprimary amines in order to mimic the structural features
of the host defense peptides, which typically contain
multiple lysine residues.[15] The cationic ammonium
groups of peptide side chains are expected to bind to the
highly negatively charged bacterial cell surface, thus
which provides a high affinity mechanism for the
polymers to exert their antibacterial effects. This also
facilitates the selective electrostatic attraction to bacteria
cells over human cells, which have a significantly lower net
negative charge on the extracellular surface. Using this
rationale, if the electrostatic binding is a dominant factor
in their antimicrobial mechanism, polymers with quater-
nary ammonium groups could yield molecules with the
highest affinity for bacteria andmost potent antimicrobial
activity compared to polymers with primary or tertiary
ammonium groups. To test this hypothesis, we prepared
copolymers with primary, tertiary, or quaternary ammoni-
um groups (Figure 7A).[24,28] The replacement of these
primary amine groups with tertiary amines or quaternary
ammoniummoieties resulted in diminished antimicrobial
activity (Figure 7B). Based on these initial structure-activity
data, we further hypothesized that the chemical structure
of the cationic groups in the polymer side chain plays a keyFigure 7. Role of amine functionality in antimicrobial mechanism. (A
ammonium groups and a dansyl end group. (B) Characteristics an
tertiary, or quaternary ammonium groups. a)Mole percentage of me
determined by 1H NMR analysis. The number-average weight (Mn) w
similar MPmethyl and DP . (C) Fluorescence emission from dansyl group
between octanol and water in the absence and presence of pho
P¼ [Polymer]octanol/[Polymer]water. The data are adapted with permi
Macromol. Biosci. 20
 2013 WILEY-VCH Verlag Gmwww.MaterialsViews.comrole in not only electrostatic binding of polymers to
bacterial membranes, but also the molecular mechanism
of membrane insertion and disruption.
What is the role of the primary ammonium group in the
mechanism of membrane disruption? To address this
question, we first investigated the affinity of polymers
for lipid membrane using a representative set of polymers
with different ammonium groups.[28] Again, each polymer
end group was covalently attached to the membrane-
sensitive dye dansyl for determining the binding behavior
of these polymers to lipid membranes as described above
(Figure 6). We used liposomes consisting of POPC as model
lipids for initial testing. This zwitterionic lipid is a
representative model for human RBC membranes, and
results can be qualitatively compared with the lytic
activity of the polymers against humanRBCs (HC50 values).
The experimental results of the binding of dye-labeled
copolymers to liposomes supported our hypothesis: the
fluorescence intensity of copolymers bearing primary
ammonium cationic groups increased significantly com-
pared to the other copolymers bearing tertiary or quater-
nary ammonium groups (Figure 7C). This suggests that
the primary-ammonium containing copolymers can insert) Polymer structures with (1) primary, (2) tertiary, or (3) quaternary
d biological properties of methacrylate copolymers with primary,
thyl group (MPmethyl) and the degree of polymerization (DP), were
as calculated based on the MPmethyl and DP . These copolymers have
s upon binding to lipid bilayers of POPC. (D) Partitioning of polymers
sphate surfactant DDP. The partition coefficient P is defined as
ssion[28] Copyright 2011 American Chemical Society.
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1294into the hydrophobic bilayer core more readily than other
copolymers, whereas the copolymer with quaternary
ammonium groups largely remains partitioned in the
aqueous milieu.
We speculated that the polymer with primary ammoni-
um groups binds more effectively to liposomes because of
the nature of the interaction with the phosphate lipid
headgroups, specifically a combination of electrostatic and
hydrogen-bonding effects. This is because the affinity of
polymers for lipid membranes appears to be correlated to
the ability of ammonium groups for hydrogen bonding. In
comparison to primary amines, tertiary amines areweaker
hydrogen bond donors and their interaction with phos-
phates may be inhibited by the presence of two bulky
methyl groups. Furthermore, the quaternary ammonium
salt groups are incapable of hydrogen-bonding. To test this
hypothesis, we evaluated partitioning of copolymers into
water–octanol phases in the presence and absence of a
phosphate surfactant (dodecyl phosphate, DDP), which
mimics the phospholipid functionality (Figure 7D).[28] The
copolymer with primary ammonium groups was parti-
tioned from the aqueous to the organic layer upon addition
of the anionic phosphate DDP, whereas the copolymers
with tertiary and quaternary ammonium groups are less
sensitive to the DDP. This result supports the hypothesis of
specific complexation of primary ammonium groups with
phosphate groups. This complexation also facilitates
polymer partitioning to the octanol phase, which indicates
that the complexation of primary ammonium groups to
phosphate headgroups likely enhances the polymer inser-
tion into the hydrophobic bilayer core, which ultimately
enhances the membrane disruption. The insertion of
polymers into lipid bilayers was further examined by
sum frequency generation (SFG) vibrational spectrosco-
py.[27] This technique allows for the determination of
molecular orientation within the bilayer. The SFG spectra
of copolymers with 33 mol-% of butyl side chains
showed that the butyl groups are oriented parallel to the
surface normal of lipid bilayer. This result suggests that
the hydrophobic groups of polymers are likely insert into
the hydrophobic core of lipid membrane. These results are
consistent with the results of computational studies on
the amphiphilic conformations of polymers in lipid
membranes (Figure 5).5. Cationic Polymer Functionality for
Anti-S. aureus Activity
Recently, we have expanded the types of polymer back-
bones for antibiotic development and investigated the
antimicrobial activity and toxicity of cationic PEIs.[40] PEIs
have been extensively used as drug and gene carriers in
biomedical applications because of their ability to enterMacromol. Biosci. 201
 2013 WILEY-VCH Verlag GmbHcells through endosomal escape.[58–61] In the development
of antimicrobial polymers, a number of studies reported
antimicrobial activity of PEI derivatives modified with
hydrophobic longalkyl groups[62–64] orquaternizedbyalkyl
groups to give water-soluble antimicrobial materials or
water insoluble antimicrobial coatings.[65–67] All of these
studies focused on the activity of modified PEIs, but the
PEI backbone was not considered as a contributing, and
possibly functionally active, antimicrobial material. As
such,wehave been interested in the intrinsic antimicrobial
activity of un-modified PEIs as molecular models to
investigate the antimicrobialmode of action andmolecular
mechanism driven by the cationic functionality and
structures of synthetic polymers.
We tested a series of commercially available PEIs with
different molecular weights (500–12 000 g mol1) and
polymer structures (branched and linear) (Figure 8A,B).[40]
In general, the branched PEIs (B-PEIs) showed potent
antimicrobial activity against S. aureus (MIC¼ 16–32mg 
mL1), while these B-PEIs are not active against E. coli
(MIC> 250mg mL1). On theotherhand, linear PEIs (L-PEIs)
are relatively active against both E. coli (MIC¼ 31mg mL1)
and S. aureus (MIC¼ 8mg mL1). In addition, the B-PEIs
showed no hemolytic activity up to 4 000mg mL1
while the L-PEIs are relatively hemolytic. These results
indicate that the B-PEIs appear to be selective to S. aureus
over E. coli and human RBCs. Such selective activity
has been reported previously for cationic compounds
including polynorbornene derivatives[35] and acyl-Lys
oligomers.[68] Dissection of the structure-activity relation-
ship yielding bacterial selectivity will be of great interest
for future studies.
Intrigued by the bacterial selectivity, we further exam-
ined the antimicrobial mechanism of these PEIs. We tested
the ability of PEIs to permeabilize cell membranes of
S. aureus using the membrane-potential depolarization
assay using the fluorescent dye DiSC3(5) which is sensitive
to membrane potential.[68,69] This dye accumulates in the
S. aureus cell membrane and the fluorescence emission
is self-quenched due to high local dye concentrations. If
PEIs damage the membrane, it would cause membrane
depolarization and subsequent alleviation of the self-
quenching (i.e., a resultant increases in emission intensity).
Interestingly, the B-PEIs did not cause any significant
membrane depolarization up to concentrations five times
greater than the MIC (Figure 8C). This result indicates that
membrane permeabilization is not likely to be the primary
mechanism of antimicrobial activity of B-PEIs against S.
aureus. Although thedetailedmechanism isnot clear at this
point, cationic B-PEIs could bind to anionic components in
the cell wall including cell-wall and lipoteichoic acids and
further interact with proteins and membranes in the cell,
disrupting cellular biological functions as speculated for
natural antimicrobial polymer chitosan.[70]3, 13, 1285–1299
& Co. KGaA, Weinheim www.MaterialsViews.com
Figure 8. Antimicrobial activity of PEIs. (A) Chemical structures and schematic presentations of branched and liner PEIs. (B) Characteristics
and biological properties of PEIs. a)Number-average molecular weight (Mn) was determined by aqueous GPC using PEGs as standards. (C) S.
aureus membrane depolarization induced by PEIs in HEPES buffer. A membrane-potential sensitive dye DiSC3(5) was added to S. aureus
suspension at 20 s. PEI or melittin was added at 100 s. At 200 s, melittin was added to the bacterial solution containing PEIs. The
concentrations of PEIs are the MIC of each PEI determined in Muller Hinton broth. The data are adapted with permission[40] Copyright 2012
WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
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www.mbs-journal.deOn the other hand, the L-PEIs caused substantial
depolarization of the S. aureus membrane, which is
comparable to lytic peptide melittin. This indicates that
the L-PEIs may exert their antimicrobial effect, at least in
part, bymembranedisruption. Thismode of action of L-PEIs
may reflect the potent activity against both E. coli and S.
aureus as membrane-active antimicrobial peptides show a
broad spectrum of activity in general. Notably, 1H NMR
analysis indicated that the L-PEIs have 4–11 mol-% of N-
propionyl groups still remaining in the final preparations,
after acid hydrolysis in the PEI synthesis. It is likely because
of these hydrophobic propionyl groups that the L-PEIs can
disrupt bacterial cell membranes, resulting in inhibition
of bacterial growth as shown for other amphiphilic
copolymers.
In addition to antimicrobial activity, PEIs are also
capable of inducing fusion of lipid vesicles.[71] Anionic
vesicles consisting of 1,2-dioleoyl-sn-glycero-3-phospho-
L-serine (DOPS) in the presence of PEI with MW of 600–
10 000 g mol1 undergo fusion to form larger vesicles.
Interestingly, the ability of PEIs to induce fusion of vesicles
depends on the PEI concentration (Figure 9). Dynamic light
scattering (DLS) measurement revealed that, in the case of
PEI with MW of 10 000 g mol1, the diameter of fusedMacromol. Biosci. 20
 2013 WILEY-VCH Verlag Gmwww.MaterialsViews.comvesicles showed the maximum value of 600nm around
1mM of PEI, while the higher or lower PEI concentrations
did not affect the vesicle size (Figure 9A). PEIs-induced
lipid mixing between vesicles through membrane
fusion was further evaluated by means of F€orster
resonance energy transfer (FRET)-based lipid mixing
assay.[72] We used an FRET pair consisting of N-(7-nitro-
benz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-




vesicles were independently prepared and pre-mixed with
each other prior to the addition of the PEIs. The interve-
sicular lipid mixing was detected as recovery of the donor
fluorescence observed at 530nm (I530) due to the dilution
of donor/acceptor pair in the membrane originated in
the fusion between dye-labeled and unlabeled vesicles
(Figure 9B). We observed that addition of PEI showed
apparent increase of I530 in a specific concentration range
(0.1–1mM), in which an apparent increase of vesicular size
was also observed. These results indicate that the PEIs
have specific concentration regions for enhancing mem-
brane fusion.Our results show that PEIs bound to liposomal13, 13, 1285–1299
bH & Co. KGaA, Weinheim 1295
Figure 9. Membrane fusion induced by PEI (MW¼ 10000 g mol1). (A) Effect of the PEI on the size distribution of DOPS vesicles as
evaluated by DLS. (B) Concentration dependence of the PEI on fluorescence intensity at 530 nm (I530) as an index of lipid mixing in FRET-
based assay and zeta potential of DOPS vesicles. (C) Cryo-TEM images of the DOPS vesicles in the presence of the PEI at various
concentrations (Bar¼ 100nm). The data are adapted with permission[71] Copyright 2012 Elsevier.
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mediate concentrations tested but NOT at the highest
concentrations. This can be thought of as a ‘‘sweet spot’’
of balance between bilayer destabilization induced by PEI
binding and electrostatic repulsions between PEIs associat-
ed with different vesicles (Figure 9C). At the intermediate
concentrations, PEIs create enough disruption of bilayer
packing order, allowing for vesicles to fuse however do
NOT impart enough surface charge to prevent close
approach of fusion partner vesicles. However, at the
high PEI concentrations, the high density of PEIs on
the liposomal surface inhibits the interactions between
vesicles due to electrostatic repulsions between high net
positive charges present on the liposome surfaces, as
confirmed by the zeta-potential measurement (Figure 9B).
These results indicate that PEIs are capable of modulating
interactions between anionic cell membranes which
represent the properties of bacterial cell membranes. PEIs
have been extensively used in biomedical applications;
however, to the best of our knowledge, the interactions of
PEIs with bacterial cell wall and cell membranes have not
been investigated systematically, and theunderstandingof
biological function of PEIs in bacteria cells is limited.Macromol. Biosci. 201
 2013 WILEY-VCH Verlag GmbHSynthetic polymers such PEIs are very cost-effective
compared to other drugs and peptides and will serve as
models for the design and mechanism of future anti-
microbial polymers.6. Conclusion and Future Perspectives
In summary,wehave developed a number of antimicrobial
copolymers based on the mimicry of naturally occurring
antimicrobial peptides. The copolymers showed antimicro-
bial activity against a broad spectrum of bacteria including
drug-resistant S. aureus. Importantly, these copolymers did
not result in the resistance development in E. coli after
over 21 passages in the presence of the copolymers while
the MICs of conventional antibiotic norfloxacin increased
up to 512-fold under the same conditions. The activity of
copolymers was modulated using the snorkeling effect
exerted by cationic elongated side chains. These activity
profiles represent the hallmarks of antimicrobial peptides,
and these peptide-inspired design approaches have
been successfully translated to improve the antimicrobial
activity of synthetic polymers.3, 13, 1285–1299
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www.mbs-journal.deFrom these results, antimicrobial polymers offer a great
deal of promise for development of new antimicrobial
materials which are less susceptible to the emergent and
current resistance mechanisms in bacteria. The develop-
ment of these new polymers and compounds provides the
basis to further investigate their potential clinical and
industrial applications. While this promise is evident,
it does not come without the need for significantly
enhanced studies into the mechanism of action of the
compounds and their physiological relevance. One of the
complicating factors in this line of study is that the parent
model, the antimicrobial peptides, is not fully understood
in terms of molecular mechanism.[74–77] This is partially
because of the number and sequence variability in
naturally occurring host defense peptides. In addition, it
has been recently reported that the antimicrobial peptides
have lowaffinitymultiple targets inbacteria, contrasting to
conventional antibiotics which have high affinity specific
targets.[15,16,78,79] Therefore, the antimicrobial activity of
peptides may rise from the results from assembles of each
component of mechanism or their synergistic effects. The
antimicrobial peptides-mimetic polymers may inherit
this complexity of mechanism, which would require new
methodology to elucidate the molecular mechanism of
antimicrobialpolymers.Alternatively,useofpolymersmay
be able to dissect these mechanisms by targeting different
functions and thus isolating molecular properties relevant
for specific aspects of molecular action.
As future perspectives to the research filed of antimicro-
bial polymers, continuing research interest is the develop-
ment of novel polymers and macromolecules. The myriad
of possibilities afforded by the variety of copolymer
building blocks expands the possibilities for new active
compounds with variable or tailored activity. In this
regard, we have recently developed cationic block copoly-
mers which displayed selective activity against E. coli
over human RBCs while the counterpart random copoly-
mers showed high hemolytic activity.[46] The macro-
molecular approach will offer new design of antimicrobial
materials fromnanoscale particles to possiblymacroscopic
gels,[32,39,80] which are not readily accessible by single
peptides. For example, Nederberg et al. have recently
prepared a biodegradable cationic nanoparticle by self-
assembly of block copolymers, which is likely to exert
an antimicrobial effect by attacking bacterial cell mem-
branes.[39] The nanoparticle showed a broad spectrum
of activity and is effective against bacterial infections in
vivo. These new approaches will open new avenues to
designing polymers and macromolecules with new and
tunable antimicrobial activity profiles while adding
functionalities such as biodegradability and additional
payload delivery.
In addition to the development of new materials, there
will be a continual need for biophysical, cellular, andMacromol. Biosci. 20
 2013 WILEY-VCH Verlag Gmwww.MaterialsViews.commicrobiological characterization of novel compounds to
elucidate mechanism of action. As seen from the experi-
ences with development of antimicrobial polymers based
on antimicrobial peptides, retaining specific molecular
signatures does not guarantee identical mechanism
when applied to bacteria. This also gives rise a need for
further development of new methodology to answer
biophysical questions for these systems. New methods
for characterizing cellular binding mechanisms, mecha-
nism of membrane permeability, and intracellular inter-
actions are necessary as the activity of antimicrobial
polymers is tuned to be more specific and targeted in
nature. These novel methodsmay also be directed at better
mimicry of the physiological environment, such that
biophysical measurements can more accurately reflect
the behavior of antimicrobial materials in the in vivo
conditions.
Finally, of specific interest to the field is the deeper
understanding of the complex relationship between
bacteria, host, and antimicrobial polymers.[77,81–84] As
noted, the antimicrobial polymers mimic many aspects
of the antimicrobial peptide mechanism of action when
studied from a biophysical perspective as well as with
respect to invitro cellular,microbiological, andbiochemical
assays. That said, there are still many unanswered
questions regarding the specific, mechanistic details of
the interactions between antimicrobial polymers and
the bacteria they are targeting. This includes not only the
detailed mechanism of action, which is likely variable
between polymer classes, but also the bacterial responses
to these compounds which relate to resistance mecha-
nisms.[85–88] This lack of understanding is equally evident
regarding the systemic host response to the polymers and
to anymetabolic or reaction side-products created through
the bacteriolytic functions. In particular, the bacterial
responses to antimicrobial exposure have recently gar-
nered significant interest with regard to development of
antimicrobial materials [85–89] although there is a dearth
of information regarding bacterial responses to anti-
microbial polymers. Numerous studies have been per-
formed to investigate the bacterial transcriptional
responses to antimicrobial peptide exposure. The results
provided insight into the relationships of antimicrobial
mechanism with bacterial resistance as well as the
activation mechanism of virulence factors upon anti-
microbial exposure. Antimicrobial peptide exposure has
also been shown to modulate bacterial motility and the
ability to form biofilms, an important consideration when
dosing antimicrobial materials.[85–90] These studies will
provide a starting point for investigating antimicrobial
polymers and their action.
Overall the future is promising for the development of
antimicrobial polymers that can transition from the
laboratory to the clinic or to applied materials. The ease13, 13, 1285–1299
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1298and cost effective synthesis of polymers combined with
variety of building blocks presents tremendous opportu-
nities for the development of new, tunable, highly effective
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